Joe Reynolds leverages the knowledge of the pharmaceutical and medical device industries to derive insights and maximize value for all members of the Noble healthcare team. His experience includes work… Read More »
Desperate for relief, many people living with inflammatory bowel disease (IBD)—either Crohn’s disease or ulcerative colitis—rely on biologic therapies that require users to self-inject. Because self-injecting can be a daunting… Read More »
Desperate for relief, many people living with psoriasis and atopic dermatitis rely on biologic therapies that require users to self-inject. Because self-injecting can be a daunting task—evidenced by the 45%… Read More »
ORLANDO – May 1, 2019 – Noble, the global leader in medical device training solutions, patient onboarding strategies and multisensory product development for the world’s top pharmaceutical brands, unveiled today… Read More »
Desperate for relief, many people living with rheumatoid arthritis (RA) and other chronic conditions rely on biologic therapies that require users to self-inject. Because self-injecting can be a daunting… Read More »
For patients living with Rheumatoid Arthritis, Crohn’s or other autoimmune diseases, one of the hardest parts of dealing with the condition may be the need to self-inject medication. While doctors… Read More »